Abbott warned on Thursday it expects more than $1 billion in financial headwinds this year from a sharp decline in COVID-19 ...

As the United States emerges from the Omicron wave, Covid-19 testing has slowed to a fraction of what it was at the beginning of the year, but experts caution that it remains an important tool in ...

Abbott Laboratories shares slumped Thursday after the drugmaker narrowed its full-year outlook, even as it posted better-than ...

Narrow-moat Quest Diagnostics posted decent third-quarter results that illustrated another quarter of solid demand for non-COVID-19 tests that partially offset the significant decline in COVID-19 ...

Coronavirus testing turnaround time has improved since the early months of the pandemic, according to a new report, but it still isn’t fast enough — and racial disparities in testing persist.

The U.S. is experiencing an increase of COVID-19, with weekly hospital admissions and test positivity rates on the rise, according to federal data.

The U.S. is experiencing an increase of COVID-19, with weekly hospital admissions and test positivity rates on the rise, according to federal data.

Amid a surge in Covid-19 cases, demand for at-home test kits is also on the rise, but test manufacturers say they are prepared to meet customer needs.

The U.S. is experiencing an increase of COVID-19, with weekly hospital admissions and test positivity rates on the rise, according to federal data.

The U.S. is experiencing an increase of COVID-19, with weekly hospital admissions and test positivity rates on the rise, according to federal data.

Major U.S. pharmacy chains are experiencing high volumes of sales of COVID-19 rapid test kits in the wake of rising case counts and hospitalizations, leading some to worry about possible product ...